République Française Inserm
Institut thématique Immunologie, inflammation, infectiologie et microbiologie

2021 International Nidovirus Symposium

The Federation of European Microbiological societies (FEMS) organises the : 

 

NIDO2021 

XVth International Nidovirus symposium 


7-8 June 2021

Online symposium
 


Voici la dernière mise à jour du programme des journées.

L'inscription est payante (¤ 95) sur le site dédié au symposium.

Date limite pour soumettre un abstract : 26 mars 2021

 

The Federation of European Microbiological Societies (FEMS) organises the XVth International Nidovirus Symposium. The Nidovirus symposium is a traditionally triennial gathering of researchers and scientists active in the field of the Nidoviruses, a broad group of pathogens of humans and animals such as the zoonotic SARS- and MERS-coronaviruses, common cold viruses, and many economically highly relevant livestock viruses. The meeting hence provides a unique international forum for sharing scientific results and exchanging ideas.
 

Program 

The symposium will cover the entire field of the nidoviruses, including an obvious emphasis on the new SARS coronavirus. Speakers will present their most recent and ground-breaking results and scientific insights in the molecular biology, host-pathogen interactions, immune responses to infection, viral immune evasion strategies, pathogenesis, mechanisms of (cross-species) transmission, epidemiology and development of vaccines and antiviral therapies.

The program will consist of :

  • 4 plenary sessions (20 speakers)
  • 2 breakout sessions with 3 rounds of 4 parallel presentations (altogether 24 speakers)
  • 2 poster sessions, each with 2 rounds
  • opportunities to separately arrange virtual get-togethers with one or more colleagues for scientific or personal exchange

Researchers are invited to submit abstracts for oral presentation to be selected either for the remaining slots in the plenary sessions (20 min) or for the breakout sessions (15 min).

Abstracts can also be submitted for poster presentation, to be on view during the entire meeting and open for discussion during one of the poster sessions. 
 

The Federation of European Microbiological Societies offers grants for congress participation for Early Career Researchers

 

Speakers include 

Keynote and opening speaker:

George Fu Gao, Director-General, Chinese Center for Disease Control and Prevention
COVID-19: the virus origin and vaccine development

 

Session I: Keynote & Virus Structure Entry :

Kwok Yung Yuen, University of Hong Kong
Mechanism of cell entry by SARS-CoV-2


Raoul de Groot, Utrecht University, Utrecht, The Netherlands
The glycobiology of human and non-human embecoviruses; relevance for (pre)attachment and cross species transmission

David Veesler, University of Washington, Seattle, USA
Structure-guided design of a SARS-CoV-2 subunit vaccine

 

Session II: Viral Replication and Virus-Host Interactions:

Volker Thiel, University of Bern, Switzerland
It’s been a long way…20 years of coronavirus reverse genetics

Montserrat Barcena, Leiden University Medical Center, Leiden, The Netherlands
Zooming in on the Coronavirus Replication Organelle

Ralph Baric, University of North Carolina at Chapel Hill, Chapel Hill, USA
Polygenic Traits Regulate Coronavirus Pathogenesis in Genetic Reference Populations

 

Session III: Epidemiology, Virus Transmission and Pathogenesis

Zhengli Shi, Wuhan Institute of Virology, Wuhan, China
Evolutionary Conservative of Receptor Usage of SARS-related Coronaviruses

Malik Peiris, University of Hong Kong
MERS Coronaviruses in Africa: A Zoonotic Threat?

 

Session IV: Immune Response to Viruses and Viral Evasion Mechanisms

Stanley Perlman, University of Iowa, Iowa City, USA
Mouse models for COVID-19 

Michel Nussenzweig, The Rockefeller University, USA
Human Immune Responses to SARS-CoViD-2 Infection and Vaccination

Ying fang, University of Illinois at Urbana-Champaign, USA
Multifunctionality of arterivirus deubiquitinase

 

Session IV: Immune Response to Viruses and Viral Evasion Mechanisms

Still to be announced